Business
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
(NewsDirect) Contact Details Proactive Canada Proactive Canada +1 604...
About this update from Cardiol Therapeutics Inc. Class A
[{"type":"text","content":"Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis\n \n \n (NewsDirect)\n \n \n \n \n \n Contact\nDetails\n \n \n \n \n Proactive Canada\n \n \n \n Proactive\nCanada\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2022 TheNewswire - All rights reserved.\n \n \n","length":1117,"tagName":"div"}]